+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Non-Hodgkin Lymphoma Treatment Market.: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4803403
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • AbbVie
  • Amgen, Inc.
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Nordic Nanovector ASA
  • MORE
The report on the global non-hodgkin lymphoma treatment market. provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global non-hodgkin lymphoma treatment market. to grow with a CAGR of 7.2% over the forecast period from 2019-2025. The study on non-hodgkin lymphoma treatment market. covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on non-hodgkin lymphoma treatment market. is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global non-hodgkin lymphoma treatment market. over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global non-hodgkin lymphoma treatment market. over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • The rising prevalence of non-Hodgkin lymphoma disease
  • The increase in research and development of therapeutic drugs against the disease
2) Restraints
  • The high cost of the treatment
3) Opportunities
  • The improvement in non-Hodgkin lymphoma treatments is giving opportunity
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global non-hodgkin lymphoma treatment market. is segmented on the basis of treatment type, and cell type.

The Global Non-hodgkin Lymphoma Treatment Market. by Treatment Type
  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy
  • Radiation
  • Stem Cell Transplant
The Global Non-hodgkin Lymphoma Treatment Market. by Cell Type
  • B-Cell
  • T-Cell
Company Profiles
The companies covered in the report include
  • AbbVie
  • Nordic Nanovector ASA
  • Pharmacyclics, LLC
  • Bayer AG
  • Novartis International AG
  • Eli Lilly and Company
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd
  • Other Companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the non-hodgkin lymphoma treatment market.
2. Complete coverage of all the segments in the non-hodgkin lymphoma treatment market. to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global non-hodgkin lymphoma treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie
  • Amgen, Inc.
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Nordic Nanovector ASA
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Non-Hodgkin Lymphoma Treatment Market Highlights
2.2. Non-Hodgkin Lymphoma Treatment Market Projection
2.3. Non-Hodgkin Lymphoma Treatment Market Regional Highlights

3. Global Non-Hodgkin Lymphoma Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Treatment Type
3.4.2. Growth Matrix Analysis by Cell Type
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Non-Hodgkin Lymphoma Treatment Market

4. Non-Hodgkin Lymphoma Treatment Market Macro Indicator Analysis

5. Global Non-Hodgkin Lymphoma Treatment Market by Treatment Type
5.1. Immunotherapy
5.2. Chemotherapy
5.3. Targeted Therapy
5.4. Radiation
5.5. Stem Cell Transplant

6. Global Non-Hodgkin Lymphoma Treatment Market by Cell Type
6.1. B-Cell
6.2. T-Cell

7. Global Non-Hodgkin Lymphoma Treatment Market by Region 2019-2025
7.1. North America
7.1.1. North America Non-Hodgkin Lymphoma Treatment Market by Treatment Type
7.1.2. North America Non-Hodgkin Lymphoma Treatment Market by Cell Type
7.1.3. North America Non-Hodgkin Lymphoma Treatment Market by Country
7.2. Europe
7.2.1. Europe Non-Hodgkin Lymphoma Treatment Market by Treatment Type
7.2.2. Europe Non-Hodgkin Lymphoma Treatment Market by Cell Type
7.2.3. Europe Non-Hodgkin Lymphoma Treatment Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Non-Hodgkin Lymphoma Treatment Market by Treatment Type
7.3.2. Asia-Pacific Non-Hodgkin Lymphoma Treatment Market by Cell Type
7.3.3. Asia-Pacific Non-Hodgkin Lymphoma Treatment Market by Country
7.4. RoW
7.4.1. RoW Non-Hodgkin Lymphoma Treatment Market by Treatment Type
7.4.2. RoW Non-Hodgkin Lymphoma Treatment Market by Cell Type
7.4.3. RoW Non-Hodgkin Lymphoma Treatment Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Non-Hodgkin Lymphoma Treatment Market
8.2. Companies Profiles
8.2.1. AbbVie
8.2.2. Nordic Nanovector ASA
8.2.3. Pharmacyclics, LLC
8.2.4. Bayer AG
8.2.5. Novartis International AG
8.2.6. Eli Lilly and Company
8.2.7. Amgen, Inc.
8.2.8. F. Hoffmann-La Roche Ltd
8.2.9. Other Companies

9. Appendix
9.1. Primary Research Findings and Questionnaire

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AbbVie
  • Nordic Nanovector ASA
  • Pharmacyclics, LLC
  • Bayer AG
  • Novartis International AG
  • Eli Lilly and Company
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd
Note: Product cover images may vary from those shown
Adroll
adroll